Patents by Inventor Janet Ahern

Janet Ahern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5690928
    Abstract: Methods and compositions for treating bladder cancer using TGF-alpha or EGF fused to PE.sub.40 or cysteine modified derivatives are taught. Also, a method of producing TGF-alpha-PE.sub.40 derivatives of enhanced potency is described.
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: November 25, 1997
    Assignee: Merck & Co., Inc.
    Inventors: David C. Heimbrook, Allen I. Oliff, Steven M. Stirdivant, Janet Ahern